Saturday, November 7, 2014
HALL B
|
|
08:30-10:30
|
Hemophilia and factor XI deficiency
|
Chairpersons
|
Claude Negrier, France Edward Tuddenham, UK
|
08:30-08:50 |
State of the Art: Treatment of women with rare bleeding disorders: Current perspectives Paula Bolton-Maggs, UK
|
08:50-09:40 08:50 09:10 09:30
|
Debate: Factor XI patients should receive replacement prior to delivery Yes: Paula Bolton-Maggs, UK No: Ophira Salomon, Israel Discussion |
09:40-10:30
09:40 10:00 10:20
|
Debate: Future standard care of adults with hemophilia would be new longer acting concentrates, applied for bleeding prophylaxis and surgery Yes: Claude Negrier, France No: Edward Tuddenham, UK Discussion |
HALL A
|
|
10:50-13:00
|
Acquired coagulopathies
|
Chairpersons
|
Pier M. Mannucci, Italy Anna Falanga, Italy
|
10:50-11:45
10:50 11:10 11:30
|
Debate: How to handle invasive procedures in patients with chronic liver disease
The views of the haematologist: Pier M. Mannucci, Italy
The views of the hepatologist: Ton Lisman, Italy
Discussion
|
11:45-12:40
11:45 12:05 12:25
|
Debate: Is the platelet number a thrombosis risk factor in myeloproliferative neoplasms?
Yes: Gunnar Birgegard, Sweden
No: Anna Falanga, Italy Discussion
|
12:40-12:50
|
Allo-, and autoantibody against Factor XIII a subunit. The antibodies exerted multiple inhibitory effect on Factor XII activation/activity and resulted in severe bleeding with fatal outcome László Muszbek, Hungary
|
12:50-13:00
|
Blood rheological properties and platelets hemostasis in cancer Irina Tikhomirova, Russia
|
HALL B |
|
14:00-15:40 |
Cancer bleeding and thrombosis |
Chairpersons |
Anna Falanga, Italy Menno Huisman, The Netherlands
|
14:00-15:00
14:00
14:20 14:40
|
Debate: Is there a role for new oral anticoagulants in the treatment of venous thromboembolism in cancer patients?
Yes: Peter Verhamme, Belgium No: Giancarlo Agnelli, Italy Discussion
|
15:00-15:20
|
State of the Art: Should incidental pulmonary embolism in cancer patients be treated as much as symptomatic pulmonary embolism?
Menno Huisman, The Netherlands
|
15:20-15:40 |
State of the Art: The role of coagulation proteins in cancer Anna Falanga, Italy
|